Vestal Point Capital, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001974915

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 48 positions · Total reported value $943.96M · Top-10 concentration 61.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 64.6% · 14 new · 20 cut · 19 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -13.4% · vs SPY -15.5% · Prev Value $4.28B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.9% · vs SPY -5.1% · Latest Value $3.87B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2023 13F filing, Vestal Point Capital, LP disclosed 48 equity positions with a combined reported value of $943.96M. The filing implies a focused portfolio: its ten largest positions account for 61.6% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were NBIX ($105.41M), JAZZ ($89.17M), ASND ($78.72M). By sector, the heaviest allocations are Health Care 81.5%, Other 18.5%.

Versus the prior quarter, Vestal Point Capital, LP opened 14 new positions, trimmed 20 and fully exited 19, a turnover rate of 64.6% of positions.

The largest new positions opened in Q4 2023 were NBIX ($105.41M), JAZZ ($89.17M), ASND ($78.72M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • NBIX NEUROCRINE BIOSCIENCES INC · $105.41M
  • JAZZ JAZZ PHARMACEUTICALS PLC · $89.17M
  • ASND ASCENDIS PHARMA A/S · $78.72M
  • INBX INHIBRX BIOSCIENCES INC · $58.14M
  • SLNO SOLENO THERAPEUTICS INC · $52.33M
  • MRK MERCK & CO INC · $43.61M
  • GMED GLOBUS MED INC · $42.63M
  • PCRX PACIRA BIOSCIENCES INC · $40.49M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Vestal Point Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Vestal Point Capital, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 63 US equity positions with a combined value of $3.87B. HoldingsHub carries 12 quarters of its filings (Q4 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-127682 (status: Approved), registered 2023-04-14
  • Regulatory AUM (Form ADV): $5.47B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: vestalpoint.com

Portfolio Structure

  • 63 positions · $3.87B reported value (Q3 2026)
  • Top 10 holdings = 67.3% of reported value
  • Largest position: ABVX (ABIVAX SA) at 10.1%
  • Average position size: $61.44M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 14 new, 22 added, 20 reduced, 19 exited
  • 7 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.5%
Other 18.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 800.00K $105.41M 11.17%
11.17%
New
2 725.00K $89.17M 9.45%
9.45%
New
3 625.00K $78.72M 8.34%
8.34%
New
4 1.53M $58.14M 6.16%
6.16%
New
5 1.30M $52.33M 5.54%
5.54%
New
6 400.00K $43.61M 4.62%
4.62%
New
7 800.00K $42.63M 4.52%
4.52%
New
8 1.20M $40.49M 4.29%
4.29%
New
9 1.62M $38.38M 4.07%
4.07%
New
10 525.00K $32.97M 3.49%
3.49%
New
11 900.00K $27.89M 2.96%
2.96%
New
12 3.92M $26.57M 2.81%
2.81%
New
13 1.66M $24.64M 2.61%
2.61%
New
14 2.10M $22.11M 2.34%
2.34%
New
15 1.00M $21.78M 2.31%
2.31%
New
16 725.00K $20.79M 2.20%
2.20%
New
17 75.00K $19.41M 2.06%
2.06%
New
18 225.00K $17.16M 1.82%
1.82%
New
19 250.00K $16.84M 1.78%
1.78%
New
20 450.00K $16.01M 1.70%
1.70%
New
21 3.00M $15.72M 1.67%
1.67%
New
22 300.00K $14.92M 1.58%
1.58%
New
23 200.00K $14.72M 1.56%
1.56%
New
24 4.16M $13.92M 1.48%
1.48%
New
25 1.02M $12.33M 1.31%
1.31%
New
26 400.00K $9.05M 0.96%
0.96%
New
27 10.00K $8.78M 0.93%
0.93%
New
28 2.70M $8.72M 0.92%
0.92%
New
29 175.00K $8.06M 0.85%
0.85%
New
30 1.02M $6.92M 0.73%
0.73%
New
31 35.00K $6.70M 0.71%
0.71%
New
32 130.00K $5.28M 0.56%
0.56%
New
33 1.29M $4.82M 0.51%
0.51%
New
34 50.00K $4.17M 0.44%
0.44%
New
35 60.00K $3.33M 0.35%
0.35%
New
36 2.15M $2.97M 0.31%
0.31%
New
37 200.00K $2.09M 0.22%
0.22%
New
38 135.00K $1.40M 0.15%
0.15%
New
39 1.40M $1.35M 0.14%
0.14%
New
40 440.00K $792.00K 0.08%
0.08%
New
41 400.00K $640.00K 0.07%
0.07%
New
42 322.67K $635.66K 0.07%
0.07%
New
43 115.00K $476.10K 0.05%
0.05%
New
44 546.07K $341.29K 0.04%
0.04%
New
45 85.43K $275.08K 0.03%
0.03%
New
46 34.09K $209.28K 0.02%
0.02%
New
47 20.31K $179.91K 0.02%
0.02%
New
48 108.08K $96.09K 0.01%
0.01%
New

FAQ

What did Vestal Point Capital, LP buy in 2023-Q4?

In its 2023-Q4 13F filing, Vestal Point Capital, LP reported 48 equity positions worth $943.96M in aggregate; its largest disclosed positions were NBIX ($105.41M), JAZZ ($89.17M), ASND ($78.72M).

How large is Vestal Point Capital, LP's portfolio?

Vestal Point Capital, LP reported $943.96M of long equity holdings across 48 positions as of 2023-Q4. Top-10 holdings account for 61.6% of reported value.

What is Vestal Point Capital, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/vestal-point-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →